A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry

Joanne Bareng, Iman Jilani, Mercedes Gorre, Hagop Kantarjian, Francis Giles, Alison Hannah, Maher Albitar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint Dive into the research topics of 'A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry'. Together they form a unique fingerprint.

Medicine & Life Sciences